Navigation Links
Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
Date:2/20/2008

lue of third party asset-backed commercial paper amounted to a loss of $1,184,000 for the quarter and year ended December 31, 2007 and represents a provision recorded on the valuation of asset-backed commercial paper held by the Company. Refer to Liquidity and Capital Resources section for more details.

Foreign exchange loss amounted to $54,000 for the current quarter (gain of $1,130,000 for the year), compared to a gain of $245,000 for the same quarter in the previous year (loss of $280,000 for the year). Foreign exchange gains or losses arise on the movement in foreign exchange rates in relation to the Company's net monetary assets denominated in currencies other than US dollars, which is its functional and reporting currency, and consists primarily of monetary assets and liabilities denominated in Canadian dollars. Foreign exchange gains recognized for the year ended December 31, 2007, are mainly attributable to the strengthening of the Canadian dollar compared to the US dollar during the period.

Other income amounted to $287,000 for the current quarter ($1,274,000 for the year), compared to $282,000 for the same quarter in the previous year ($1,348,000 for the year). Other income consists of non-operating revenue, primarily sub-lease revenue. The 2006 income includes an amount of $293,000 in respect of the recovery of prior years' property taxes.

Share of loss in a company subject to significant influence amounted to nil for the current quarter ($327,000 for the year), compared to $489,000 for the corresponding quarter in the previous year ($2,440,000 for the year). Non-controlling interest amounted to nil for the current quarter ($109,000 for the year), compared to $162,000 for the corresponding quarter in the previous year ($801,000 for the year). These items result from the consolidation of the Company's interest in a holding company (Innodia Holding) that owns shares of Innodia Inc., for which Neurochem is the primary beneficiary. The sh
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
2. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
3. Neurochem to present at JPMorgan Healthcare Conference
4. Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
5. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
6. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
7. Neurochem reports results for third quarter of fiscal 2007
8. Emageon Reports Fourth Quarter and 2007 Financial Results
9. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
10. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... (PRWEB) May 28, 2015 The connected ... so that nearly all new vehicles have some iteration ... huge implications to the motor insurance companies as the ... is otherwise known as usage-based insurance (UBI). This is ... at The Insurance Telematics Europe 2015 Conference & Exhibition. ...
(Date:5/28/2015)... Sexual Health Innovations, a nonprofit ... health and wellbeing in the United States, announced ... (USF) will be the first institution to adopt ... reporting system. , Callisto is designed to ... experience for college sexual assault survivors, to give ...
(Date:5/28/2015)... Westport, CT (PRWEB) May 28, 2015 ... mobile monitoring software, announced their partnership with ... their kids’ online activity. The partnership ... programs with WebWatcher’s comprehensive parental monitoring software ... Detective Rich Wistocki, BeSure Consulting's passion is ...
(Date:5/28/2015)... 28, 2015 The drug epidemic has struck ... article published on May 12th, 2015, by Bradenton , ... of time. The first victim, Dylan Besser (21) was a ... the scene. The second overdose victim, Julian Toomsen-Hall (18) was ... the alarming overdose deaths on campus, the college has created ...
(Date:5/28/2015)... The MIT Sloan Center for Information ... IQ. Members of the MIT CISR research team interviewed ... develop the case study about Healthcare IQ’s business model ... case study, ‘Healthcare IQ: Competing as the “Switzerland” of ... as a hospital financial software provider through its evolution ...
Breaking Medicine News(10 mins):Health News:TU-Automotive: North America’s Leading Insurers Head to Chicago as Connected Car Motor Insurance Shifts up a Gear 2Health News:TU-Automotive: North America’s Leading Insurers Head to Chicago as Connected Car Motor Insurance Shifts up a Gear 3Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3Health News:WebWatcher Partners with BeSure Consulting 2Health News:WebWatcher Partners with BeSure Consulting 3Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 2Health News:Two College Campus Deaths Force Sarasota College to Create Drug Task Force 3Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3
... The Drug Digoxin or Digitalis, which comes from the foxglove ... by maintaining the rhythm of the heart and treat heart ... the team of researchers from University of Wisconsin-Madison to make ... as neo (new)-glyco (sugar)-randomisation, which works by changing the sugars ...
... cancers are preventable by changes in our life style and ... helps. To lose weight one should also have fiber rich ... dietary guidance: "Diets rich in fruits and vegetables may reduce ... diseases." These foods are rich with antioxidants and protect the ...
... UK functional food developer has entered into an initial three-year ... endorse its new juice drink Sirco. ,The product, ... trials to reduce the risk of thrombosis, a major cause ... Heart UK logo and also carry the claim:,‘Helps to maintain ...
... big bang, bringing hope and aspirations for people// around the world. ... 2001 opened with it Pandora ’s Box of both natural disasters ... disaster was in 2000 on February 1st in California when a ... whole string of disasters followed. ,Droughts hitting India, the ...
... comparing people on two different types of low fat, low ... consumed a traditional diet consisting of lean meats and other ... by about 4.6 percent. However, those who consumed a diet ... did about twice as well, lowering their LDL levels by ...
... determining transplant eligibility say researchers ,as a recent ... just as well as their younger counterparts. // ... a heart transplant at the University of Alberta Hospital ... rates were followed for up to 11 years following ...
Cached Medicine News:Health News:Top Ten Super Food Items That Can Help In Avoiding Cancer 2Health News:SARS (Bird Flu) spreading in the Asian continent 2
(Date:5/28/2015)... May 28, 2015  Array BioPharma Inc. (NASDAQ: ... selumetinib (licensed to AstraZeneca) at the 2015 American Society ... held May 29 – June 2, 2015 in ... currently advancing in a total of 6 pivotal trials, ... NEMO (binimetinib monotherapy in NRAS mutant melanoma patients) and ...
(Date:5/28/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... trial that will also be discussed in an ... Oncology (ASCO) Annual Meeting in Chicago ... superiority study of patients with locally-advanced, nonsquamous non-small ... ®  (pemetrexed for injection), in combination with cisplatin ...
(Date:5/28/2015)... , May 28, 2015  Cardinal Health today ... acquire Johnson & Johnson,s Cordis business for $1.944 billion ... after consultations with relevant works councils and trade unions. ... the United States and key non-U.S. countries ... and other customary closing conditions. Headquartered in ...
Breaking Medicine Technology:Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 2Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 3PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 2PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 3PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 4PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 5PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 6PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 7PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 8Cardinal Health Binding Offer To Acquire Cordis Accepted 2Cardinal Health Binding Offer To Acquire Cordis Accepted 3Cardinal Health Binding Offer To Acquire Cordis Accepted 4
... www.healthtech.net ), the Ultimate Connectivity Partner in long-term ... Quality Assurance.  In a single system, clinicians use ... to enhance quality care planning and proactive treatment.  ... Reporting for providers wanting to position successful wound ...
... Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced ... Citi 2012 Global Health Care Conference on Wednesday, February 29, ... at the Waldorf=Astoria in New York City. Jack Lief, Arena,s ... corporate overview. A live audio webcast of the ...
Cached Medicine Technology:American HealthTech Announces Comprehensive Wound Management 2Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 2Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 3
1.25 mm x 2.5 mm blade. 135 degrees back scratcher. Round handle....
6 mm wide tip. Gentle tapered blade. Designated most popular model or size....
9 mm wide tip. Designated most popular model or size....
4 mm wide tip....
Medicine Products: